Literature DB >> 30041013

The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.

Steffen E Storck1, Anika M S Hartz2, Jessica Bernard1, Andrea Wolf3, André Kachlmeier1, Anne Mahringer4, Sascha Weggen5, Jens Pahnke6, Claus U Pietrzik7.   

Abstract

The accumulation of neurotoxic amyloid-beta (Aβ) in the brain is a characteristic hallmark of Alzheimer's disease (AD). The blood-brain barrier (BBB) provides a large surface area and has been shown to be an important mediator for removal of brain Aβ. Both, the ABC transporter P-glycoprotein (ABCB1/P-gp) and the receptor low-density lipoprotein receptor-related protein 1 (LRP1) have been implicated to play crucial roles in Aβ efflux from brain. Here, with immunoprecipitation experiments, co-immunostainings and dual inhibition of ABCB1/P-gp and LRP1, we show that both proteins are functionally linked, mediating a concerted transcytosis of Aβ through endothelial cells. Late-onset AD risk factor Phosphatidylinositol binding clathrin assembly protein (PICALM) is associated with both ABCB1/P-gp and LRP1 representing a functional link and guiding both proteins through the brain endothelium. Together, our results give more mechanistic insight on Aβ transport across the BBB and show that the functional interplay of different clearance proteins is needed for the rapid removal of Aβ from the brain.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABC transporter B1/P-glycoprotein (ABCB1/P-gp); Alzheimer’s disease (AD); Amyloid-beta (Aβ); Blood-brain barrier (BBB); Clearance; Endothelial cell; Endothelium; Low-density lipoprotein receptor-related protein 1 (LRP1); Phosphatidylinositol-binding clathrin assembly protein (PICALM); Transcytosis

Mesh:

Substances:

Year:  2018        PMID: 30041013      PMCID: PMC7748946          DOI: 10.1016/j.bbi.2018.07.017

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  52 in total

1.  Inactivation of the proximal NPXY motif impairs early steps in LRP1 biosynthesis.

Authors:  Sara M Reekmans; Thorsten Pflanzner; Philip L S M Gordts; Simone Isbert; Pascale Zimmermann; Wim Annaert; Sascha Weggen; Anton J M Roebroek; Claus U Pietrzik
Journal:  Cell Mol Life Sci       Date:  2009-10-25       Impact factor: 9.261

Review 2.  The Role of PICALM in Alzheimer's Disease.

Authors:  Wei Xu; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2014-09-04       Impact factor: 5.590

3.  Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.

Authors:  Chia-Chen Liu; Jin Hu; Na Zhao; Jian Wang; Na Wang; John R Cirrito; Takahisa Kanekiyo; David M Holtzman; Guojun Bu
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

4.  Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model.

Authors:  Sabrina Meister; Steffen E Storck; Erik Hameister; Christian Behl; Sascha Weggen; Albrecht M Clement; Claus U Pietrzik
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-08       Impact factor: 6.200

Review 5.  Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease.

Authors:  T Pflanzner; C R Kuhlmann; C U Pietrzik
Journal:  Curr Alzheimer Res       Date:  2010-11       Impact factor: 3.498

6.  Decreased clearance of CNS beta-amyloid in Alzheimer's disease.

Authors:  Kwasi G Mawuenyega; Wendy Sigurdson; Vitaliy Ovod; Ling Munsell; Tom Kasten; John C Morris; Kevin E Yarasheski; Randall J Bateman
Journal:  Science       Date:  2010-12-09       Impact factor: 47.728

7.  Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.

Authors:  Steffen E Storck; Sabrina Meister; Julius Nahrath; Julius N Meißner; Nils Schubert; Alessandro Di Spiezio; Sandra Baches; Roosmarijn E Vandenbroucke; Yvonne Bouter; Ingrid Prikulis; Carsten Korth; Sascha Weggen; Axel Heimann; Markus Schwaninger; Thomas A Bayer; Claus U Pietrzik
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

8.  MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.

Authors:  Diana Kuhnke; Gabriele Jedlitschky; Markus Grube; Markus Krohn; Mathias Jucker; Igor Mosyagin; Ingolf Cascorbi; Lary C Walker; Heyo K Kroemer; Rolf W Warzok; Silke Vogelgesang
Journal:  Brain Pathol       Date:  2007-07-04       Impact factor: 6.508

9.  Identification and confirmation of an exonic splicing enhancer variation in exon 5 of the Alzheimer disease associated PICALM gene.

Authors:  Nathalie C Schnetz-Boutaud; Joshua Hoffman; Jared E Coe; Deborah G Murdock; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Ann Hum Genet       Date:  2012-09-04       Impact factor: 1.670

10.  Expression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-β peptide.

Authors:  Agnès Dodacki; Matthew Wortman; Bruno Saubaméa; Stéphanie Chasseigneaux; Sophie Nicolic; Nathalie Prince; Murielle Lochus; Anne-Laure Raveu; Xavier Declèves; Jean-Michel Scherrmann; Shailendra B Patel; Fanchon Bourasset
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

View more
  33 in total

1.  Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography.

Authors:  Viktoria Zoufal; Severin Mairinger; Markus Krohn; Thomas Wanek; Thomas Filip; Michael Sauberer; Johann Stanek; Claudia Kuntner; Jens Pahnke; Oliver Langer
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-13       Impact factor: 6.200

2.  Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood-Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells.

Authors:  Hinako Nagano; Shingo Ito; Takeshi Masuda; Sumio Ohtsuki
Journal:  Pharm Res       Date:  2021-11-22       Impact factor: 4.200

3.  Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).

Authors:  Andaleeb Sajid; Natarajan Raju; Sabrina Lusvarghi; Shahrooz Vahedi; Rolf E Swenson; Suresh V Ambudkar
Journal:  Drug Metab Dispos       Date:  2019-08-01       Impact factor: 3.922

Review 4.  Meningeal Lymphatics: From Anatomy to Central Nervous System Immune Surveillance.

Authors:  Zachary Papadopoulos; Jasmin Herz; Jonathan Kipnis
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

5.  Meprin β: A novel regulator of blood-brain barrier integrity.

Authors:  Markus Gindorf; Steffen E Storck; Anke Ohler; Franka Scharfenberg; Christoph Becker-Pauly; Claus U Pietrzik
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-16       Impact factor: 6.200

6.  Healthy aging and the blood-brain barrier.

Authors:  William A Banks; May J Reed; Aric F Logsdon; Elizabeth M Rhea; Michelle A Erickson
Journal:  Nat Aging       Date:  2021-03-15

7.  Imaging P-Glycoprotein Induction at the Blood-Brain Barrier of a β-Amyloidosis Mouse Model with 11C-Metoclopramide PET.

Authors:  Viktoria Zoufal; Severin Mairinger; Mirjam Brackhan; Markus Krohn; Thomas Filip; Michael Sauberer; Johann Stanek; Thomas Wanek; Nicolas Tournier; Martin Bauer; Jens Pahnke; Oliver Langer
Journal:  J Nucl Med       Date:  2019-12-05       Impact factor: 11.082

8.  Inflammatory Cytokine IL-1β Downregulates Endothelial LRP1 via MicroRNA-mediated Gene Silencing.

Authors:  Heng-Wei Hsu; Carlos J Rodriguez-Ortiz; Joannee Zumkehr; Masashi Kitazawa
Journal:  Neuroscience       Date:  2020-11-24       Impact factor: 3.590

9.  Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment.

Authors:  Naveed Ullah Khan; Jiang Ni; Xiufeng Ju; Tongtong Miao; Haiyan Chen; Liang Han
Journal:  Acta Pharm Sin B       Date:  2020-10-21       Impact factor: 11.413

10.  Brain endothelial LRP1 maintains blood-brain barrier integrity.

Authors:  Steffen E Storck; Magdalena Kurtyka; Claus U Pietrzik
Journal:  Fluids Barriers CNS       Date:  2021-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.